Rhein-Kreis Neuss launches tender worth EUR 155 million for Medical Science City project

Rhein-Kreis Neuss in Germany has issued a EUR 155 million competitive tender for the planning, construction, and operation of a model Medical Science City focused on cell and gene therapies.

Rhein-Kreis Neuss has published a competitive tender valued at up to EUR 155 million for the comprehensive planning, construction, and operation of a model Medical Science City (MSC) located in Germany. As the local public administration governing the Rhein-Kreis Neuss district in North Rhine-Westphalia, Rhein-Kreis Neuss is responsible for regional economic development, public infrastructure, and administrative governance. Under this initiative, the contracting authority aims to establish an integrated center for biomedical research, development, and production to accelerate the transfer of academic research into commercialized, marketable products.

The procurement encompasses the end-to-end planning, construction, and operation of the MSC facility on a designated site within the district. The contractor’s scope of work includes selecting and connecting suitable academic start-ups and technology-oriented small and medium-sized enterprises (SMEs) to the district, alongside managing all building-related operations such as maintenance, repairs, warehouse logistics, energy supply, IT infrastructure, validation, building services, Good Manufacturing Practice (GMP) certification, and state-of-the-art laboratory infrastructure.

This major development highlights a strategic public commitment to bridging the gap between early-stage academic innovation and commercial biotechnology manufacturing. By securing financial support through the State of North Rhine-Westphalia and European Regional Development Fund (ERDF) funds, the project mitigates early-stage venture risk and establishes a dedicated infrastructure pipeline for advanced therapeutic development.

The initiative impacts the biotechnology, pharmaceutical, commercial healthcare real estate, and specialized engineering sectors across the North Rhine-Westphalia region and broader European life sciences ecosystem. For academic spin-offs and biotechnology SMEs, the center guarantees access to specialized, capital-intensive manufacturing facilities and GMP-certified spaces that are typically cost-prohibitive for early-stage ventures.

For global investors, engineering firms, and biomedical operators, this procurement offers a long-term strategic anchor in one of Europe’s leading industrial and research hubs. Establishing commercial infrastructure for advanced therapies creates sustainable economic spillovers, positions the district as a specialized life sciences hub, and yields valuable long-term market opportunities for operational partners.

This tender is published on Bidsinfo.com, and the full tender details are available on https://www.bidsinfo.com/ref/36938038/st-26017-competitive-dialogue-planning-construction-and-operation-of-the-medical-science-city-in-the.